Results 201 to 210 of about 40,710 (290)

Taurochenodeoxycholic acid alleviates obesity-induced endothelial dysfunction. [PDF]

open access: yesEur Heart J
Lu H   +17 more
europepmc   +1 more source

The secretory protein, CLCF1, improves cholestatic liver disease by inhibiting hepatic bile acid synthesis and promoting bile acid excretion. [PDF]

open access: yesCommun Biol
Liu M   +12 more
europepmc   +1 more source

Bile acid signaling, metabolism, and aging. [PDF]

open access: yesLiver Res
Sun J, Zhang S, Jin L, Huang W.
europepmc   +1 more source

Sevelamer inhibits the formation of cholesterol gallstones by modulating bile acid metabolism. [PDF]

open access: yesFront Pharmacol
Shen S   +8 more
europepmc   +1 more source

Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study. [PDF]

open access: yesSci Rep
da Silva MAE   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy